NORTHERN TRUST CORP - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 85 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$368,156
-59.7%
344,071
-2.5%
0.00%
Q2 2023$914,399
-36.7%
353,050
-0.3%
0.00%
Q1 2023$1,444,410
-16.5%
354,022
+2.7%
0.00%
Q4 2022$1,730,290
-61.0%
344,679
+1.7%
0.00%
-100.0%
Q3 2022$4,434,000
+1.3%
339,071
-0.6%
0.00%0.0%
Q2 2022$4,375,000
-2.1%
341,251
+16.4%
0.00%0.0%
Q1 2022$4,470,000
-17.1%
293,106
-3.7%
0.00%0.0%
Q4 2021$5,394,000
-14.3%
304,514
+1.7%
0.00%0.0%
Q3 2021$6,295,000
+7.3%
299,460
+0.7%
0.00%0.0%
Q2 2021$5,866,000
-26.3%
297,440
+8.6%
0.00%0.0%
Q1 2021$7,960,000
-2.5%
273,840
+1.6%
0.00%
-50.0%
Q4 2020$8,164,000
+86.1%
269,472
-2.3%
0.00%
+100.0%
Q3 2020$4,386,000
-15.1%
275,696
+5.4%
0.00%0.0%
Q2 2020$5,165,000
+58.4%
261,639
-1.0%
0.00%0.0%
Q1 2020$3,260,000
-32.8%
264,402
+0.8%
0.00%0.0%
Q4 2019$4,849,000
+246.1%
262,239
+159.1%
0.00%
Q3 2019$1,401,000
+107.6%
101,211
+119.7%
0.00%
Q2 2019$675,00046,0660.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,766,666$59,928,00049.90%
Greenspring Associates, LLC 1,573,357$25,032,00038.95%
Svennilson Peter 18,017,932$286,665,00023.39%
Aquilo Capital Management, LLC 1,018,334$16,202,0001.72%
Jasper Ridge Partners, L.P. 308,750$4,912,0000.28%
Samsara BioCapital, LLC 36,451$580,0000.16%
Rock Springs Capital Management LP 360,454$5,735,0000.15%
Point72 Asset Management, L.P. 1,611,850$25,645,0000.13%
Virtus ETF Advisers LLC 14,880$237,0000.12%
WELD CAPITAL MANAGEMENT LLC 15,238$242,0000.10%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders